News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerner Corporation (CERN) Receives FDA Clearance for Cerner Bridge Transfusion Administration and Specimen Collections



6/28/2007 2:10:46 PM

KANSAS CITY, Mo.--(BUSINESS WIRE)--Cerner Corp. (Nasdaq: CERN) announced today that Cerner Bridge™ Transfusion Administration and Specimen Collections software solution has received U.S. Food and Drug Administration (FDA) 510(k) pre-market notification clearance. Cerner will immediately make this solution available to clients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES